NAGA anticorps (AA 312-411)

N° du produit ABIN6144342

Détail du produit anti-NAGA anticorps

Antigène: NAGA (N-Acetylgalactosaminidase, alpha (NAGA))

Épitope: AA 312-411

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NAGA est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF)

Séquence: IQGRRIHKEK SLIEVYMRPL SNKASALVFF SCRTDMPYRY HSSLGQLNFT GSVIYEAQDV YSGDIISGLR DETNFTVIIN PSGVVMWYLY PIKNLEMSQQ

Réactivité croisée: Humain, Souris, Rat

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 312-411 of human NAGA (NP_000253.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000,IF,1:50 - 1:200

Commentaires:

HIGH QUALITY

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur NAGA

Antigène: NAGA (N-Acetylgalactosaminidase, alpha (NAGA))

Autre désignation: NAGA (NAGA Produits)

Synonymes: anticorps D22S674, anticorps GALB, anticorps alpha-N-acetylgalactosaminidase, anticorps N-acetyl galactosaminidase, alpha, anticorps Naga, anticorps NAGA

Sujet: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).,NAGA,D22S674,GALB,Cancer,Signal Transduction,Endocrine & Metabolism,NAGA

Poids moléculaire: 46 kDa

ID gène: 4668

UniProt: P17050